11.

Restructuring

In February 2013, the Company’s Board of Directors approved a restructuring plan of up to $15.0 million to migrate the delivery of services, primarily in the Product Development segment, and to reduce anticipated overcapacity in selected areas, primarily in the Integrated Healthcare Services segment. These actions are expected to continue throughout 2013 and are expected to result in severance for approximately 400 positions. The Company recognized approximately $3.2 million and $5.2 million of total restructuring costs related to this plan during the three and six months ended June 30, 2013, respectively. All of the restructuring costs are related to severance costs, with approximately $2.8 million and $1.9 million related to activities in the Product Development segment and in the Integrated Healthcare Services segment, respectively. The remaining charge of approximately $407,000 was related to corporate activities. Restructuring costs are not allocated to the Company’s reportable segments as they are not part of the segment performance measures regularly reviewed by management.

As of June 30, 2013, the following amounts were recorded for the restructuring plans (in thousands):


			Severance and Related Costs									Exit Costs
	Balance at December 31, 2012		Expense, Net of Reversals			Payments			Foreign Currency Translation			Expense, Net of Reversals			Payments			Foreign Currency Translation			Balance at June 30, 2013
2013 Plan	$	—	$	5,166		$	(3,797	)	$	(24	)	$	—		$	—		$	—		$	1,345
2012 Plan		11,220		(252	)		(7,449	)		(98	)		—			—			—			3,421
Prior Year Plans		1,564		(193	)		(531	)		(13	)		(25	)		(43	)		(1	)		758

	$	12,784	$	4,721		$	(11,777	)	$	(135	)	$	(25	)	$	(43	)	$	(1	)	$	5,524